Cannabis News
Market-moving headlines, earnings, and regulatory shifts across the cannabis sector
Track the developments that move cannabis stocks — from quarterly earnings and M&A deals to state-level legalization votes and federal policy changes. Articles are tagged with relevant stock tickers so you can see which companies are affected and jump straight to their market data.
Nevada Cannabis Laws Create Investment Headwinds Despite Legal Status
Nevada's complex public consumption restrictions limit cannabis market growth potential, creating regulatory uncertainty that impacts sector valuations.
Healthcare Giants Eye Cannabis as Medical Market Expands
Major healthcare services companies position for cannabis integration as regulatory barriers diminish and patient acceptance grows nationwide.
Blueberries Medical Corp Surges 19.2% on Elevated Trading Volume
BBRRF climbed to $0.01 on 26,100 shares traded, representing significant volatility for the micro-cap international cannabis company.
Indiana Stalls on Cannabis While National Legalization Wave Accelerates
Indiana remains among shrinking list of prohibition states as cannabis legalization momentum builds across US markets, creating investment opportunities.
Virginia Cannabis Policy Shift Creates Regional Market Opportunities
Virginia's evolving marijuana stance opens doors for local markets in Danville and Pittsylvania County, signaling broader state-level cannabis expansion trends.
Senate Bill Grants States Hemp THC Override Powers
Bipartisan legislation would let states bypass federal hemp-derived THC restrictions, reshaping the $28B hemp market regulatory framework.
Cannabis Reduces Prescription Drug Dependence, New Research Confirms
Fresh clinical data shows medical cannabis patients successfully reduce opioid and sleep medication use, strengthening the investment case for pharma-focused operators.
Cannabis Substitution Study Validates $30B Medical Market Expansion
New research on 3,500+ patients shows medical cannabis effectively replaces opioids and prescription drugs, strengthening industry growth thesis.
cbdMD Inc (YCBD) Tumbles 5.4% Amid Ongoing Market Pressures
YCBD shares fell to $0.72 on elevated volume as the CBD company continues trading near multi-year lows despite maintaining solid gross margins.
CV Sciences Tumbles 12.4% as CBD Company Struggles at $0.04
CV Sciences dropped 12.4% to $0.04 on elevated volume of 530,821 shares, highlighting ongoing challenges in the CBD sector.
US Cannabis Legalization Stalls Despite Rising Public Support
Federal cannabis reform faces political headwinds despite widespread voter approval, creating uncertainty for industry growth and investment prospects.
Cannabist Company Sees 330% Volume Surge Amid Penny Stock Rally
CBSTF trades 3.3x average volume at 5.4M shares as the multi-state operator gains 4.29% to $0.03 per share.
Texas Medical Cannabis Awareness Gap Creates Policy Expansion Opportunity
New polling reveals strong voter support for medical marijuana despite limited knowledge of existing program, signaling potential for regulatory expansion.
Texas Cannabis Confusion: 75% Support Medical Marijuana Despite Ignorance
New polling reveals massive disconnect between voter support for medical cannabis and awareness of Texas's restrictive existing program.
Heritage Cannabis Brands Target Cultural Shift for 4/20 Marketing Push
Rolling paper manufacturers pivot messaging strategy as cannabis culture evolves beyond traditional consumption patterns during peak sales season.
Mainstream Brands Embrace Cannabis Culture as Market Normalization Accelerates
Jimmy John's 4/20 campaign with Cheech Marin signals corporate America's shift from cannabis avoidance to active engagement, boosting sector legitimacy.
Cannabis Tax Burden Hits $2.24B as 280E Crushes Legal Operators
Legal cannabis companies paid $2.24 billion in excess federal taxes in 2025 under Section 280E, creating effective tax rates up to 70% that threaten industry viability.
Pre-Rolls Capture $3.6B to Become Cannabis Industry's Top Category
Pre-rolls generated $3.6 billion in 2024 revenue with 383 million units sold, overtaking flower as the dominant product category in U.S. cannabis markets.
Massachusetts Halts Cannabis Cultivation Licenses as Prices Crater
Bay State regulators freeze new grow permits for four months as cannabis flower prices plummet to $14 per eighth, signaling oversupply crisis.
Verano Holdings Plunges 8.7% as MSO Sector Faces Headwinds
Multi-state operator Verano Holdings dropped 8.7% to $1.26 amid broader cannabis sector weakness and elevated trading volume.